Table 3.
Total | Women | Men | ||||
---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
HIV infection | 1.21 (1.01-1.46) | 0.043 | 1.76 (1.24-2.52) | 0.002 | 1.05 (0.84-1.32) | 0.639 |
Female gender | 0.59 (0.51-0.69) | <0.001 | N/A | N/A | N/A | N/A |
Age | 1.07 (1.06-1.08) | <0.001 | 1.06 (1.05-1.07) | <0.001 | 1.07 (1.07-1.08) | <0.001 |
White race (vs. all others) | 0.98 (0.85-1.13) | 0.780 | 0.92 (0.69-1.24) | 0.597 | 1.01 (0.86-1.19) | 0.869 |
Hypertension | 1.22 (1.04-1.44) | 0.013 | 1.41 (1.01-1.99) | 0.046 | 1.19 (0.99-1.43) | 0.061 |
Diabetes | 1.10 (0.93-1.29) | 0.259 | 1.03 (0.74-1.44) | 0.854 | 1.11 (0.92-1.34) | 0.271 |
Dyslipidemia | 0.71 (0.61-0.83) | <0.001 | 0.72 (0.53-0.99) | 0.044 | 0.71 (0.60-0.84) | <0.001 |
Smoking (ever vs. never) | 1.28 (1.12-1.47) | <0.001 | 1.20 (0.90-1.60) | 0.210 | 1.30 (1.12-1.52) | 0.001 |
Structural heart disease | 2.25 (1.91-2.65) | <0.001 | 2.13 (1.53-2.97) | <0.001 | 2.28 (1.89-2.75) | <0.001 |
Atrial fibrillation/flutter | 1.34 (1.06-1.70) | 0.014 | 1.60 (0.96-2.66) | 0.072 | 1.28 (0.98-1.67) | 0.068 |
Aspirin use | 0.77 (0.66-0.91) | 0.002 | 1.00 (0.71-1.40) | 0.996 | 0.71 (0.59-0.86) | <0.001 |
Warfarin use | 0.68 (0.53-0.88) | 0.003 | 0.70 (0.41-1.20) | 0.196 | 0.67 (0.51-0.89) | 0.005 |
Abbreviations: HR = hazard ratio.